Table 4.

Univariate analyses of factors associated with poor outcomes (chronic renal insufficiency, refractory HTN, and/or death) in patients with Takayasu arteritis. Values are n (%) unless otherwise specified.

VariablesPatients without Poor Outcome*, n = 47Patients with Poor Outcome*, n = 15p
Age > 35 yrs26 (55.3)9 (60)0.750
Male/female, n7/402/131.000
Delay in diagnosis, > 1 yr22 (46.8)9 (60)0.554
Elevated ESR at presentation28 (59.6)9 (60)0.977
Elevated CRP at presentation15 (31.9)2 (13.3)0.314
Renal insufficiency at presentation§3 (6.4)5 (33.3)0.016
HTN at presentation30 (63.8)14 (93.3)0.047
Diabetes at presentation2 (4.3)1 (6.7)1.000
Dyslipidemia at presentation6 (12.8)3 (20.0)0.674
Limb claudication15 (31.9)7 (46.7)0.359
Decreased pulse35 (74.5)15 (100.0)0.029
Asymmetric blood pressure39 (83.0)13 (86.7)1.000
Vascular bruit14 (29.8)5 (33.3)1.000
Bilateral involvement23 (48.9)12 (80.0)0.041
Severity > 70%17 (36.2)9 (60.0)0.137
Antihypertensive drug
  Any30 (63.8)14 (93.3)0.047
  ACE inhibitor or ARB10 (21.3)7 (46.7)0.094
  B blocker9 (19.1)8 (53.3)0.018
  Calcium-channel blocker24 (51.1)14 (93.3)0.005
Antiplatelet drug
  Any29 (61.7)9 (60.0)1.000
  Aspirin22 (46.8)9 (60.0)0.554
Cholesterol-lowering drug26 (55.3)8 (53.3)1.000
Warfarin8 (17.0)4 (26.7)0.461
Corticosteroid31 (66.0)7 (46.7)0.363
Immunosuppressant30 (63.8)6 (40.0)0.228
Revascularization7 (14.9)4 (26.7)0.437
  • Significant data are in bold face.

  • * Poor outcome was defined as the composite of chronic renal insufficiency, refractory HTN, and/or death.

  • Defined as ESR > 9 mm/h in men, > 20 mm/h in women.

  • Defined as CRP > 0.6 mg/dl.

  • § Defined as an estimated glomerular filtration rate < 60 ml/min. HTN: hypertension; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; ACE: angiotensin-converting enzyme; ARB: angiotensin receptor blocker.